Quality Resource Guide

Techniques for Early Cancer Detection 2nd Edition

www.metdental.com

References

American Cancer Society. Cancer Facts & Figures 2021.

Atlanta: American Cancer Society; 2021.

Lingen MW, Tampi MP, Urquhart O, et al. Adjuncts for

the evaluation of potentially malignant disorders in the

oral cavity: Diagnostic test accuracy systematic review

and meta-analysis-a report of the American Dental

Association. J Am Dent Assoc 2017;148:797-813.e52.

National Cancer Institute. SEER Cancer Stat Facts: Oral

Cavity and Pharynx Cancer. Available at: https://seer.

cancer.gov/statfacts/html/oralcav.html . Accessed March

15, 2021.

Li L, Morse DE, Katz RV. What constitutes a proper

routine oral cancer examination for patients at low risk?

Findings from a Delphi survey. Oral Surg Oral Med Oral

Pathol Oral Radiol 2013;116:e379-86.

Seoane J, Alvarez-Novoa P, Gomez I, Takkouche B, et

al. Early oral cancer diagnosis: The Aarhus statement

perspective. A systematic review and meta-analysis.

Head Neck 2016;38 Suppl 1:E2182-9.

Holmes JD, Dierks EJ, Homer LD, Potter BE. Is detection

of oral and oropharyngeal squamous cancer by a dental

health care provider associated with a lower stage at

diagnosis? J Oral Maxillofac Surg 2003;61:285-91.

Gallop. One-Third of Americans Haven’t Visited Dentist

in Past Year. Available at:

http://www.gallup.com/

poll/168716/one-third-americans-haven-visited-dentist-

past-year.aspx.

Accessed March 20, 2018.

Purkayastha M, McMahon AD, Gibson J, Conway DI. Is

detecting oral cancer in general dental practices a realistic

expectation? A population-based study using population

linked data in Scotland. Br Dent J 2018;225(3):241-246.

Stefanuto P, Doucet JC, Robertson C. Delays in treatment

of oral cancer: a review of the current literature. Oral Surg

Oral Med Oral Pathol Oral Radiol 2014;117:424-9.

10.

Scott SE, Grunfeld EA, McGurk M. Patient’s delay in

oral cancer: A systematic review. Community Dent Oral

Epidemiol 2006;34:337-43.

11.

Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Lo

Muzio L. Oral and pharyngeal cancer: lack of prevention

and early detection by health care providers. Eur J

Cancer Prev 2001;10:381-3.

12.

National Cancer Institute. Oral Cavity, Pharyngeal,

and

Laryngeal

Cancer

Screening

(PDQ®)–

Health Professional Version.

Available at:

http://

www.cancer.gov/cancertopics/pdq/screening/oral/

HealthProfessional/page2 .

Accessed March 20, 2018.

13.

Silverman S Jr, Kerr AR, Epstein JB. Oral and pharyngeal

cancer control and early detection. J Cancer Educ

2010;25:279-81.

14.

Brouha XD, Tromp DM, Koole R, et al. Professional

delay in head and neck cancer patients: analysis of the

diagnostic pathway. Oral Oncol 2007;43:551-6.

15.

American Dental Association. CDT 2017 dental

procedure codes. Chicago, 2016.

16.

Lingen MW, Abt E, Agrawal N, et al. Evidence-

based clinical practice guideline for the evaluation of

potentially malignant disorders in the oral cavity: A

report of the American Dental Association. J Am Dent

Assoc 2017;148:712-727.e10

17.

ClearCyte Diagnostics. Oral cancer. Available at: http://

www.clearcyte.com/cancer/oral-cancer/ . Accessed

March 20, 2018.

18.

Huber MA. Adjunctive Diagnostic Techniques for Oral

and Oropharyngeal Cancer Discovery. Dent Clin North

Am 2018;62:59-75

19.

OralCDx. What is the OralCDx Brush Test? Available

at: https://thebrushtest.com/what-is-the-brushtest/ .

Accessed March 20, 2018.

20.

Eisen D, Frist S. The relevance of the high positive

predictive value of the oral brush biopsy. Oral Oncol

2005;41:753-5

21.

Mehrotra R, Mishra S, Singh M, Singh M. The efficacy

of oral brush biopsy with computer-assisted analysis in

identifying precancerous and cancerous lesions. Head

Neck Oncol 2011;24;3:39.

22.

Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical

evaluation of diagnostic aids for the detection of oral

cancer. Oral Oncol 2008;44:10-22.

23.

Bhoopathi V, Kabani S, Mascarenhas AK. Low positive

predictive value of the oral brush biopsy in detecting

dysplastic oral lesions. Cancer 2009;115:1036-1040.

24.

Fedele S. Diagnostic aids in the screening of oral

cancer. Head Neck Oncol 2009 Jan 30;1:5.

25.

Cheng YS, Rees T, Wright J. Updates Regarding

Diagnostic Adjuncts for Oral Squamous Cell Carcinoma.

Tex Dent J 2015;132:538-49.

26.

Koch FP, Kunkel M, Biesterfeld S, Wagner W.

Diagnostic efficiency of differentiating small cancerous

and precancerous lesions using mucosal brush smears

of the oral cavity--a prospective and blinded study. Clin

Oral Investig 2011;15:763-9.

27.

Chhabra N, Chhabra S, Sapra N. Diagnostic modalities

for squamous cell carcinoma: an extensive review of

literature-considering toluidine blue as a useful adjunct.

J Maxillofac Oral Surg 2015;14:188-200.

28.

Silverman S Jr, Migliorati C, Barbosa J. Toluidine blue

staining in the detection of oral precancerous and

malignant lesions. Oral Surg Oral Med Oral Pathol

1984;57:379-82.

29.

Epstein JB, Güneri P. The adjunctive role of toluidine

blue in detection of oral premalignant and malignant

lesions. Curr Opin Otolaryngol Head Neck Surg

2009;17:79-87.

30.

Zhang L, Williams M, Poh CF, et al.

Toluidine blue

staining identifies high-risk primary oral premalignant

lesions with poor outcome. Cancer Res 2005;65:8017-21.

31.

Richards D. Does toluidine blue detect more oral cancer?

Evid Based Dent 2010;11:104-5.

32.

FDA website. Premarket notification K033033.

Available

at:

http://www.accessdata.fda.gov/cdrh_docs/pdf3/

K033033.pdf . Accessed March 20, 2018.

33.

FDA website. Premarket notification K121282.

Available

at: https://www.accessdata.fda.gov/cdrh_docs/pdf12/

K121282.pdf . Accessed March 20, 2018.

34.

Huber MA, Epstein JB. Marketing versus science: a call

for evidence-based advertising in dentistry. Oral Surg

Oral Med Oral Pathol Oral Radiol. 2015;120:541-3.

35.

Poh CF, Zhang L, Anderson DW, et al. Fluorescence

visualization detection of field alterations in tumor margins

of oral cancer patients. Clin Cancer Res 2006;12:6716-

22.

36.

Rashid A, Warnakulasuriya S. The use of light-based

(optical) detection systems as adjuncts in the detection

of oral cancer and oral potentially malignant disorders: a

systematic review. J Oral Pathol Med 2015;44:307-28.

37.

Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash

and chemiluminescent illumination as an adjunct to

conventional oral soft tissue examination for the detection

of dysplasia: a pilot study. Quintessence Int 2004;35:378-

84.

38.

Liu J, Duan Y. Saliva: A potential media for disease

diagnostics and monitoring. Oral Oncol 2012;48:569-577.

39.

OralDNA Labs. OraRisk® HPV, Complete Genotyping

Testing From OralDNA Labs. Available at: https://www.

oraldna.com/oral-hpv-testing.html . Accessed March 20,

2018.

40.

OralDNA Labs. OraRisk® HPV 16/18/HR Testing from

OralDNA Labs. Available at:

https://www.oraldna.com/

hpv-testing.html . Accessed March 20, 2018.

41.

PeriRx. SaliMark OSCC. Available at: http://perirx.com/

products/ . Accessed March 18, 2018.

42.

Martin JL, Gottehrer N, Zalesin H, et al. Evaluation of

Salivary Transcriptome Markers for the Early Detection

of Oral Squamous Cell Cancer in a Prospective Blinded

Trial. Compend Contin Educ Dent 2015;36:365-73.

43.

Sonawane K, Suk R, Chiao EY, et al. Oral Human

Papillomavirus Infection: Differences in Prevalence

Between Sexes and Concordance With Genital Human

Papillomavirus Infection, NHANES 2011 to 2014. Ann

Intern Med 2017;167:714-724.

44.

Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C.

Epidemiology of Human Papillomavirus-Positive Head

and Neck Squamous Cell Carcinoma J Clin Oncol

2015;33:3235-42.

45.

Rettig E, Kiess AP, Fakhry C. The role of sexual

behavior in head and neck cancer: implications for

prevention and therapy. Expert Rev Anticancer Ther

2015;15:35-49.